Dr. Lawson Eng, MD, SM, FRCPC is a Medical Oncologist at the Princess Margaret Cancer Centre and Assistant Professor in the Department of Medicine, University of Toronto. He completed his medical school, internal medicine and medical oncology residency at the University of Toronto and completed his fellowship through the Royal College – Clinician Investigator Program where he jointly completed a Master of Science (SM) at the Harvard School of Public Health in epidemiology focusing on population-level data, data science and outcomes research, and his clinical and research fellowship at the Princess Margaret Cancer Centre. 

His clinical practice focuses on lung, gastrointestinal and head and neck cancers. His research interests are in cancer survivorship and supportive care with a focus on health behaviours (in particular, tobacco control), patient-reported outcomes, real-world population-level data, outcomes research and health services research with a goal towards improving the care of cancer survivors.  He currently holds a Hold’Em for Life Early Career Professorship in Cancer Research and is currently the Ontario Health – Cancer Care Ontario – Smoking Cessation Regional Lead for Toronto Central South (Princess Margaret Cancer Centre) where he is responsible for the delivery of smoking cessation across the region and he also serves on the Ontario Health – Cancer Care Ontario – Smoking Cessation Research and Knowledge Translation Committee, and the International Association of the Study of Lung Cancer (IASLC) – Tobacco Control and Smoking Cessation Committee as the Research Sub-group co-chair. Furthermore, he is involved in the Multinational Association of Supportive Care in Cancer – Research Committee, Survivorship Working Group and Disparities Task Force. To date, he has published over 75 manuscripts and has over 170 abstract presentations at international meetings. He has received multiple American Society of Clinical Oncology (ASCO) Merit Awards, Novartis Oncology Young Canadian Investigator Awards, an ASCO Young Investigator Award (2020), an IASLC Early Career Award, a MASCC Young Investigator Award (2018), the 2019 Canadian Association of Medical Oncology (CAMO) Fellowship Award and a Canadian Institutes of Health Research (CIHR) Publication Prize, CIHR Fellowship Award and CIHR Early Career Researcher Award. His research has been funded by CAMO, ASCO, CIHR and the Canadian Cancer Society Research Institute.